FDA orders shutdown at Emergent's troubled plant 2 weeks after handing J&J the keys | FiercePharma

FDA orders shutdown at Emergent's troubled plant 2 weeks after handing J&J the keys | FiercePharma: Johnson & Johnson’s takeover of COVID-19 vaccine manufacturing at an error-prone Emergent BioSolutions plant didn’t last long. At the FDA's request, Emergent stopped production just two weeks after J&J took over manufacturing its shot there.